SynthesisInternational journal of hematology2020
A presentation, treatment, and survival analysis of primary cardiac lymphoma cases reported from 2009 to 2019.
Synthesis in International journal of hematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 29 citations in OpenAlex.
- Case report: primary cardiac lymphoma presenting as acute coronary syndrome and atrioventricular block due to right coronary artery compression.European heart journal. Case reports · 2026Article
- Unveiling the invisible: the role of multimodality imaging in diagnosing primary cardiac lymphoma.The international journal of cardiovascular imaging · 2026Article
- Pericardial fluid cytology as a diagnostic tool for diffuse large B-cell lymphoma: a case report.Advances in laboratory medicine · 2026Article
- Case Report: Surgical resection combined with chemotherapy for a primary cardiac lymphoma involving right heart structures.Frontiers in oncology · 2026Article
- Electrocardiographic manifestations and targeted management of cardiac complications in cardiac-involved DLBCL: a retrospective case series.Cardio-oncology (London, England) · 2025Article
- Primary cardiac lymphoma presenting double obstruction of the right ventricle.Journal of cardiology cases · 2025Article
- Cardiac Tumors: Review.Brazilian journal of cardiovascular surgery · 2024Review
- A rare case of primary cardiac diffuse large B-cell lymphoma imaged withFrontiers in medicine · 2024Article
- Brugada phenocopy with altered ST-segment elevation in pericardial diffuse large B-cell lymphoma and effusive-constrictive pericarditis: a case report.European heart journal. Case reports · 2023Article
- Massive myocardial infiltration by primary anaplastic T-cell lymphoma: a case report.European heart journal. Case reports · 2023Article
- Primary cardiac lymphoma: a case report.European heart journal. Case reports · 2023Article
- Constrictive Pericarditis-A Cloak Camouflaging Lymphoma.Hematology reports · 2023Article
- A very rare case of extranodal B-cell non-Hodgkin lymphoma presenting with adrenal and heart involvement.Leukemia research reports · 2022Article
- Cardiac Involvement by Human Herpesvirus 8-Positive Diffuse Large B-Cell Lymphoma: An Unusual Presentation in a Patient with Human Immunodeficiency Virus.Case reports in pathology · 2022Article
- Primary Cardiac Lymphoma: A Case Report.Journal of medical cases · 2021Article
- Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors.Frontiers in oncology · 2021Article
- Cardiovascular Death Risk in Primary Central Nervous System Lymphoma Patients Treated With Chemotherapy: A Registry-Based Cohort Study.Frontiers in oncology · 2021Article
- B-cell primitive extranodal cardiac lymphoma: multimodal image diagnosis and long-term follow-up.European heart journal. Case reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The heart is a rare primary site of lymphoma, and cardiac involvement is thought to bring a poorer prognosis. A framework of known clinical presentations, diagnostic features, disease complications, treatments, and outcomes to improve prognostication was constructed by a systematic review in 2011. However, some aspects must be discussed further in light of recent advances in lymphoma research. We collected cardiac lymphoma case reports published from January 2009 to January 2019, collected statistics from each patient, and performed a systematic analysis. The epidemiological characteristics, clinical manifestations, treatments, responses, and survival of primary cardiac lymphoma (PCL) patients are described. We obtained 158 cases of heart lymphoma, of which 101 were defined as PCL. There were more male than female cases. Most cases were diffuse large B-cell lymphoma. Six cases of PCL in cardiac myxomas were described. Patients with arrhythmia had shorter progression-free survival compared those without (HR 0.334, 95% CI 0.112-0.999, log-rank P = 0.042). Surgery did not improve patients' long-term prognosis or reduce the risk of death within 1 month. These data suggest that central nervous system prophylaxis is necessary. The overall survival was longer than that in data from 1949 to 2009.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.